X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/vyera-pharmaceuticals-llc-and-phoenixus-ag-sign-asset-purchase-agreement-to-sell-rights-to-daraprim-and-vecamyl-301890830.html
https://www.forbes.com/sites/johnlamattina/2022/10/28/another-example-of-a-shkrelian-drug-price-increase/?sh=3394eb16f003
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216983
https://www.cnbc.com/2022/01/31/companies-founded-by-martin-shkreli-will-pay-in-daraprim-case.html
https://www.fiercepharma.com/pharma/shkreli-s-former-company-vyera-settles-for-40m-daraprim-antitrust-case-but-pharma-bro-has
https://endpts.com/martin-shkreli-to-go-toe-to-toe-with-new-ftc-chair-over-daraprim-price-spikes/
https://endpts.com/uk-re-investigates-pfizers-eye-popping-price-gouging-on-an-epilepsy-drug/
https://endpts.com/martin-shkreli-continued-to-orchestrate-anti-competitive-schemes-for-daraprim-behind-bars-ftc/
https://endpts.com/martin-shkrelis-infamous-daraprim-falls-off-top-20-most-expensive-drugs-list/
http://www.globenewswire.com/news-release/2020/04/15/2016587/0/en/Oakrum-Pharma-Announces-the-Launch-of-Toxo-Total-Care-Patient-Services-Program-to-Support-Pyrimethamine-25mg-Tablets.html
https://www.prnewswire.com/news-releases/fda-approves-first-generic-of-daraprim-301013549.html
https://www.ftc.gov/news-events/press-releases/2020/01/ftc-ny-attorney-general-charge-vyera-pharmaceuticals-martin
https://www.pharmacompass.com/pdf/news/Spectrum-Laboratory-Products-Receives-FDA-Warning-Letter-1560408618.pdf
https://www.biospace.com/article/study-shows-drugs-on-fda-shortage-list-are-likely-to-see-price-hikes/
https://endpts.com/the-latest-tempest-over-a-dramatic-drug-price-hike-riles-two-powerful-senators-who-cant-actually-do-anything-about-it/?utm_medium=email&utm_campaign=Friday%20September%2014%202018&utm_content=Friday%20September%2014%202018+CID_f6b8b99e5b7934eebb900b4a9fd5bbd8&utm_source=ENDPOINTS%20emails&utm_term=Problem%20is%20they%20still%20cant%20do%20anything%20about%20it
https://www.fiercebiotech.com/shkreli-stocks-still-sharing-biotech-tips
https://www.forbes.com/sites/nicolefisher/2018/06/26/sticker-shock-the-real-cost-of-americas-10-most-expensive-drugs/?ss=pharma-healthcare#1781663714d1
https://www.fiercepharma.com/pharma/sanofi-tweaks-pricing-policy-discloses-8-4-net-price-decline-2017
https://endpts.com/biotech-bad-boy-martin-shkreli-isnt-getting-his-5m-in-bail-money-back-anytime-soon/
http://raps.org/Regulatory-Focus/News/2017/08/22/28291/FDA-Warns-Compounding-Pharmacy-Finds-Wood-in-Drug-Samples/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
http://www.fiercepharma.com/legal/pharma-bro-martin-shkreli-convicted-for-securities-fraud
http://www.chicagotribune.com/business/ct-pharma-bro-martin-shkreli-trial-20170703-story.html
http://www.fiercepharma.com/legal/shkreli-jury-pool-shrinks-as-prospects-blast-pharma-bro-for-greed
http://raps.org/Regulatory-Focus/News/2017/06/12/27883/Senate-to-Take-on-Pharmaceutical-Prices-Again-Real-Reform-or-More-of-the-Same/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
https://www.bloomberg.com/news/articles/2017-06-05/drug-prices-become-target-for-fda-as-chief-expands-agency-s-view
https://www.forbes.com/sites/judystone/2017/03/11/rare-disease-patients-need-more-than-miracles-and-trumpcare/
https://www.vice.com/en_us/article/meet-the-pharmaceutical-hacker-trying-to-make-open-source-drugs
https://endpts.com/another-biotech-games-the-system-and-everyone-gets-to-pay-for-the-fallout/
http://www.fiercepharma.com/pharma/congressmen-win-bipartisan-support-for-bill-to-fight-drug-price-gouging
http://www.forbes.com/sites/johnlamattina/2017/01/27/big-drug-companies-should-secede-from-the-pharmaceutical-research-and-manufacturers-of-america/#a93ff926ad61
https://www.cnet.com/news/pharma-bro-shkreli-fires-back-at-pharma-industry-ad-blitz/
https://www.washingtonpost.com/news/wonk/wp/2017/01/18/maker-of-34000-a-vial-drug-to-pay-100-million-for-allegedly-preventing-competition/?utm_term=.b4fda52bb4f8
http://www.fiercepharma.com/pharma/pfizer-ceo-says-public-confuses-ethical-pharma-unethical-counterparts
http://www.mcall.com/business/healthcare/ct-martin-shkreli-daraprim-drug-price-20161223-story.html
http://www.reuters.com/article/us-health-naloxone-drug-pricing-idUSKBN13Y2KC
http://www.forbes.com/sites/johnlamattina/2016/12/08/gileads-ceo-apologetic-about-sovaldis-1000-per-pill-price-tag/#6ef26b077898
http://www.wsj.com/articles/pfizer-fined-107-million-for-epilepsy-drug-price-hike-1481104073
http://www.fiercepharma.com/pharma/analysts-to-wall-street-drug-pricing-brouhaha-far-from-over
http://www.fiercepharma.com/pharma/medicare-medcaid-pony-up-for-big-price-hikes-2015-data-show
http://www.sandiegouniontribune.com/business/biotech/sd-me-imprimis-lead-20161025-story.html
http://www.biospace.com/News/how-one-tweet-from-bernie-sanders-sent-ariads/435806/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
http://www.forbes.com/sites/brucejapsen/2016/10/12/these-10-drugs-are-busting-hospital-budgets/#4ae9da803d29
http://in.reuters.com/article/us-impax-labs-turing-idINKCN0Y931L
http://www.fiercepharma.com/pharma/impax-sues-turing-for-besmirching-its-rep-as-disgraced-shkreli-faces-new-indictment
https://www.statnews.com/pharmalot/2016/05/02/turing-shkreli-lawsuit/
http://www.reuters.com/article/us-usa-healthcare-drugpricing-idUSKCN0X10TH
http://www.fiercepharma.com/story/senators-lambaste-turing-unethical-price-hikes-latest-drug-price-hearing/2016-03-18
Market Place
Share 
